Vega Ploiești refinery starts producing higher-purity hexane
The Vega Ploiești Refinery, operated by Rompetrol Rafinare, has started producing hexane with a minimum purity of 60%, supporting polypropylene production and the food industry.
The Vega Ploiești Refinery, operated by Rompetrol Rafinare, has started producing hexane with a minimum purity of 60%, supporting polypropylene production and the food industry.
Rompetrol Rafinare will halt operations at its Petromidia Năvodari and Vega Ploiești refineries in early March for a scheduled technological turnaround lasting approximately 20 days.
The Kazakh-Romanian Energy Investment Fund (Kreif), through its subsidiary Rompetrol Energy, has completed commissioning of the cogeneration plant on the Petromidia Năvodari platform.
Rompetrol Rafinare has announced the signing of an amendment to a syndicated loan agreement, with a value of up to $600 million.
Since 2004, the company has carried out over 12.5 million technical analyses, directly supporting the Petromidia Navodari and Vega Ploiesti refineries.
The financial results were influenced by the planned shutdown of the Petromidia refinery, between March and May 2024.

Electrica has completed the Artificial Intelligence for Active Energy Management (AIAE) project, developed in partnership with Romanian startup Renergia and the Technical University of Cluj-Napoca.
Greenvolt Next Romania has signed an agreement with Sam Mills to develop a 2MW photovoltaic project with a 10.03 MWh battery storage system in Satu Mare.
Romania's annual inflation rate reached 10.7% in April 2026 compared to April 2025, according to data released by the National Institute of Statistics (INS).
Fitch Ratings has upgraded CEC Bank's Long-Term Issuer Default Rating from BB to BB+ with a Stable Outlook, following the publication of Fitch's updated Bank Rating Criteria on 8 May 2026.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.